These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7577067)

  • 21. Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma.
    Kakolyris S; Agelidou A; Androulakis N; Tsaroucha E; Kouroussis Ch; Agelidou M; Karvounis N; Veslemes M; Christophylakis Ch; Argyraki A; Geroyianni A; Georgoulias V
    Lung Cancer; 2006 Jul; 53(1):59-65. PubMed ID: 16716447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternating chemotherapy and accelerated split-course irradiation in locally advanced nonsmall cell lung carcinoma.
    Pignon T; Ruggieri S; Boutin C; Gouvernet J; Irisson M; Juin P; Astoul P
    Cancer; 1999 May; 85(10):2144-50. PubMed ID: 10326692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Small cell lung carcinoma: role of thoracic irradiation and its timing in relation to chemotherapy].
    Payne DG; Murray N; Warde P
    Bull Cancer; 1994 Feb; 81(2):119-28. PubMed ID: 7894117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Split-course versus continuous thoracic radiation therapy for limited-stage small-cell lung cancer: final report of a randomized phase III trial.
    Blackstock AW; Bogart JA; Matthews C; Lovato JF; McCoy T; Livengood K; Ho C; White D; Atkins JN; Miller AA
    Clin Lung Cancer; 2005 Mar; 6(5):287-92. PubMed ID: 15845179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II trial of up-front accelerated thoracic radiotherapy combined with chemotherapy and optional up-front prophylactic cranial irradiation in limited small-cell lung cancer. Groupe d'Oncologie Thoracique des Régions Alpines.
    Hügli A; Moro D; Mermillod B; Bolla M; Alberto P; Bonnefoi H; Miralbell R
    J Clin Oncol; 2000 Apr; 18(8):1662-7. PubMed ID: 10764426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase II study of combined chemoradiotherapy for limited disease-small-cell lung cancer.
    Ishihara S; Tsuchiya S; Minato K; Watanabe S; Sunaga N; Sato K; Kobayashi G; Hoshino H; Naruse I; Makimoto T; Nomoto T; Takei Y; Fueki N; Takise A; Saito R; Mori M
    Am J Clin Oncol; 2000 Apr; 23(2):197-202. PubMed ID: 10776984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combined alternating radiochemotherapy in stage III (TNM) (limited disease) small cell bronchial carcinoma: a phase II study with carboplatin/etoposide/vincristine and alternating radiotherapy].
    Serke M; Riedel U; Schönfeld N; Pannhorst J; Förster B; Loddenkemper R
    Pneumologie; 1999 Oct; 53(10):485-92. PubMed ID: 10596551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
    Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternating radiotherapy and chemotherapy in limited small cell lung cancer: the IGR protocols. French FNCLCC Lung Cancer Study Group.
    Arriagada R; Le Chevalier T; Ruffié P; Chomy P; de Cremoux H
    Lung Cancer; 1994 Mar; 10 Suppl 1():S289-98. PubMed ID: 8087522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
    Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW;
    J Clin Oncol; 2005 Aug; 23(22):4991-8. PubMed ID: 15939930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limited small cell lung cancer: possible prognostic impact of initial chemotherapy doses.
    Arriagada R; de The H; Le Chevalier T; Thomas F; Ruffie P; de Cremoux H; Martin M; Duroux P; Dewar J; Sancho-Garnier H
    Bull Cancer; 1989; 76(6):604-15. PubMed ID: 2550102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12.
    Glisson B; Scott C; Komaki R; Movsas B; Wagner H
    J Clin Oncol; 2000 Aug; 18(16):2990-5. PubMed ID: 10944132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Medical Research Council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. The Medical Research Council Lung Cancer Working Party.
    Bleehen NM; Girling DJ; Gregor A; Leonard RC; Machin D; McKenzie CG; Morgan DA; Smyth JF; Spittle MF; Stephens RJ
    Br J Cancer; 1991 Oct; 64(4):775-9. PubMed ID: 1654988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concurrent cisplatin/etoposide chemotherapy plus twice daily thoracic radiotherapy in limited stage small cell lung cancer: a phase II study.
    Mennecier B; Jacoulet P; Dubiez A; Westeel V; Bosset JF; Magnin V; Depierre A
    Lung Cancer; 2000 Mar; 27(3):137-43. PubMed ID: 10699687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of etoposide and cisplatin with concurrent twice-daily thoracic radiotherapy followed by irinotecan and cisplatin in patients with limited-disease small-cell lung cancer: West Japan Thoracic Oncology Group 9902.
    Saito H; Takada Y; Ichinose Y; Eguchi K; Kudoh S; Matsui K; Nakagawa K; Takada M; Negoro S; Tamura K; Ando M; Tada T; Fukuoka M;
    J Clin Oncol; 2006 Nov; 24(33):5247-52. PubMed ID: 17114657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
    Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study.
    Aisner J; Goutsou M; Maurer LH; Cooper R; Chahinian P; Carey R; Skarin A; Slawson R; Perry MC; Green MR
    J Clin Oncol; 1992 Aug; 10(8):1230-6. PubMed ID: 1321892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control.
    Videtic GM; Fung K; Tomiak AT; Stitt LW; Dar AR; Truong PT; Yu EW; Vincent MD; Kocha WI
    Lung Cancer; 2001; 33(2-3):249-58. PubMed ID: 11551420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy.
    Prendiville J; Radford J; Thatcher N; Steward W; Ranson M; Burt P; Stout R
    J Clin Oncol; 1991 Aug; 9(8):1446-52. PubMed ID: 1649266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early concurrent chemoradiotherapy with prolonged oral etoposide and cisplatin for limited-stage small-cell lung cancer.
    Lee SH; Ahn YC; Kim HJ; Lim DH; Lee SI; Nam E; Park SH; Park J; Lee KE; Park JO; Kim K; Kim WS; Jung CW; Im YH; Kang WK; Lee MH; Park K
    Jpn J Clin Oncol; 2003 Dec; 33(12):620-5. PubMed ID: 14769839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.